BTOG 2019 | The Manchester Lung Health Check Pilot: integrating biomarkers into screening
Philip Crosbie
The Manchester Lung Health Check Pilot has taken screening into the community, where many are at high-risk of lung cancer, as discussed here by Philip Crosbie, MBChB, MRCP, PhD, of the University of Manchester, Manchester, UK. Speaking from the British Thoracic Oncology Group (BTOG) 2019 Annual Conference in Dublin, Ireland, Dr Crosbie highlights how blood samples in the second round were used for biomarker screening, which has provided a model for patient selection for screening.
Similar topics
Related videos

Accelerate, Coordinate, Evaluate (ACE) cancer care: the CRUK programme streamlining the care pathway
Sara Hiom

Lung cancer screening in the UK: CRUK, UK NSC, Public Health England & NHS England
Sara Hiom

The Recovery Package in lung cancer
Josie Roberts

Single-port VATS for NSCLC: outcomes related to smoking status
John Edwards

Psychological impact of lung cancer screening
Mamta Ruparel
et al.
More from Philip Crosbie